Allergy & Immunology Doctors in Katy, TX Accepting Medicare

4 Allergy & Immunology doctors found. Showing 1 - 4

Mrs. Sue Ellen Perez, PA-C Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 23910 Katy Fwy Ste 201, Katy, TX 77494 Phone: 713-486-9800

Dr. Sanober M Tamboli, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 23222 Kingsland Blvd, Suite A, Katy, TX 77494 Phone: 281-693-0084    Fax: 281-693-0093

Dr. Yongxin Chen, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 21820 Kingsland Blvd, #110, Katy, TX 77450 Phone: 281-578-7922    Fax: 281-578-3175

Dr. Pardeep Singh Rihal, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 705 S Fry Rd, Suite 115, Katy, TX 77450 Phone: 281-647-9204    Fax: 281-647-9198

News Archive

Muscle rubs for pain in adults – no evidence they work

There is not enough evidence to support using gels and creams containing rubefacients for chronic and acute pain, according to a systematic review by Cochrane Researchers. Rubefacients cause irritation and reddening of the skin, due to increased blood flow. The review focused on formulations containing salicylates, which are widely prescribed or sold over the counter as topical treatments for sports injuries and muscle pain.

Roche conducts third Phase 1 clinical trial utilizing Halozyme's Enhanze Technology

Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that the first patient was dosed in a Phase 1 pharmacokinetic clinical trial using Enhanze™ Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.

COUP-TFII plays pivotal role in obesity, metabolic syndrome

A protein known to play a role in development and the formation of organs is also an important factor in the control of obesity and diabetes, said researchers from Baylor College of Medicine in a report that appears in the current issue of the journal Cell Metabolism.

Cook Medical enrolls first patient in Formula PTX Balloon Expandable Renal Stent trial

Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.

Read more Medical News

› Verified 5 days ago